Orchid Chemicals Fact Sheet, Orchid Chemicals Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Fact Sheet    (ORCHID)


Urgent Release: My Special Report on How to Trade the Coronavirus Crash


Here is the latest financial fact sheet of Orchid Chemicals. For more details, see the Orchid Chemicals quarterly results and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA LTD Price History

Price Rs 5.3
Mkt Cap Rs m 448
Vol '000 46.3
P/E X -0.4
P/CF X -0.1
EPS (TTM) Rs -12.8
% ch % -4.9
No. of shares m 85.26
% ch week % -22.3
% ch 1-mth % 17.7
% ch 12-mth % -24.7
52 week H/L Rs 8.6/3.0
(As on Jul 24, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA LTD Financials

No. of Mths
Year Ending
12
Mar-09
*
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
18
Sep-13
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA LTD EQUITY SHARE DATA
High Rs330239344325194 
Low Rs577512811235 
Sales per share (Unadj.) Rs184.1190.7253.0266.0276.5 
Earnings per share (Unadj.) Rs-7.048.222.213.8-79.2 
Diluted earnings per shareRs-5.739.818.311.4-65.5 
Cash flow per share (Unadj.) Rs12.170.241.135.7-43.5 
Dividends per share (Unadj.) Rs1.0010.003.003.000 
Adj. dividends per shareRs0.838.262.482.480.00 
Dividend yield (eoy) %0.56.41.31.40 
Book value per share (Unadj.) Rs90.0133.1151.8160.753.9 
Adj. book value per shareRs74.3110.0125.4132.844.6 
Shares outstanding (eoy) m70.4470.4470.4470.4470.45 
Bonus/Rights/Conversions  WC---ESOP 
Price / Sales ratio x1.10.80.90.80.4 
Avg P/E ratio x-27.83.310.615.8-1.4 
P/CF ratio (eoy) x16.02.25.76.1-2.6 
Price / Book Value ratio x2.21.21.61.42.1 
Dividend payout %-14.420.813.521.70 
Avg Mkt Cap Rs m13,63011,05916,62415,3918,067 
No. of employees `0004.03.7NA4.52.8 
Total wages/salary Rs m1,4091,7751,7371,7642,527 
Avg. sales/employee Rs Th3,210.03,630.9NM4,205.66,956.1 
Avg. wages/employee Rs Th348.7479.8NM396.0902.5 
Avg. net profit/employee Rs Th-121.3916.9NM218.8-1,993.0 
ORCHID PHARMA LTD INCOME DATA
Net Sales Rs m12,96913,43517,81818,73619,477 
Other income Rs m86186447562407 
Total revenues Rs m13,82913,52018,26519,29819,884 
Gross profit Rs m1,706-1,5693,5643,5661,103 
Depreciation Rs m1,3401,5491,3351,5372,519 
Interest Rs m1,5652,4231,1681,7985,227 
Profit before tax Rs m-338-5,4551,509793-6,236 
Minority Interest Rs m000020 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m010,153207-39511 
Tax Rs m1521,306154-220-125 
Profit after tax Rs m-4903,3931,562975-5,580 
Gross profit margin %13.2-11.720.019.05.7 
Effective tax rate %-44.9-23.910.2-27.82.0 
Net profit margin %-3.825.38.85.2-28.7 
ORCHID PHARMA LTD BALANCE SHEET DATA
Current assets Rs m15,95417,00515,26312,53311,014 
Current liabilities Rs m8,55810,85219,89415,51132,060 
Net working cap to sales %57.045.8-26.0-15.9-108.1 
Current ratio x1.91.60.80.80.3 
Inventory Days Days21611512713095 
Debtors Days Days1892001052234 
Net fixed assets Rs m25,54220,72220,74124,26129,440 
Share capital Rs m704704704704705 
"Free" reserves Rs m5,4798,4548,1069,3102,043 
Net worth Rs m6,3389,37710,69211,3233,800 
Long term debt Rs m26,15915,3036,04110,7429,018 
Total assets Rs m43,91639,90639,10239,38146,510 
Interest coverage x0.8-1.32.31.4-0.2 
Debt to equity ratio x4.11.60.60.92.4 
Sales to assets ratio x0.30.30.50.50.4 
Return on assets %2.414.67.07.0-0.8 
Return on equity %-7.736.214.68.6-146.9 
Return on capital %3.828.917.211.6-3.7 
Exports to sales %71.972.740.745.237.9 
Imports to sales %32.728.232.437.822.6 
Exports (fob) Rs m9,3209,7627,2598,4677,378 
Imports (cif) Rs m4,2343,7875,7737,0894,406 
Fx inflow Rs m9,59210,0527,8688,9287,513 
Fx outflow Rs m5,0065,2676,6588,2195,649 
Net fx Rs m4,5864,7851,2107091,865 
ORCHID PHARMA LTD CASH FLOW
From Operations Rs m 459 -343 3,321 7,370 1,682 
From Investments Rs m -4,770 14,128 -3,674 -2,931 -9,860 
From Financial Activity Rs m 4,311 -10,768 -778 -4,802 6,644 
Net Cashflow Rs m 0 3,016 -1,130 -362 -1,535 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 32.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.6%
FIIs 3.3%
ADR/GDR 4.6%
Free float 55.3%
Shareholders 84,811
Pledged promoter(s) holding 54.9%
 

Company Information

REGD OFF Orchid Towers, 313, Valluvar Kottam Road, Nungambakkam, Chennai-34
E-MAIL corporate@orchidpharma.com WEB www.orchidpharma.com
TELEPHONE (044) 2821 1000 FAX (044) 2827 5960
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Integrated Enterp., II Flr., Kences Tower, North Usman Rd., Chennai-17
AUDITOR SNB Associates
CHM: K. Raghavendra Rao (MD) COMP SEC: L. Chandrasekar YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  ALKEM LABORATORIES  TORRENT PHARMA  DIVIS LABORATORIES  ALEMBIC PHARMA  

Compare ORCHID PHARMA LTD With:   AUROBINDO PHARMA  ALKEM LABORATORIES  TORRENT PHARMA  DIVIS LABORATORIES  ALEMBIC PHARMA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling(Closing)

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

Views on news

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout... (The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - ACTAVIS COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS